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Biochemistry of Protein-Isocyanate
Interactions: A Comparison of the Effects
of Aryl vs. Alkyl Isocyanates
by William E. Brown,* Allen H. Green,*t Thomas E. Cedel,*
and Jennifer Cairns*
In addition to their use in the polyurethane and pesticide industries, isocyanates have proven to be
useful probes for the exploration ofprotein structure. This paper focuses on three aspects ofisocyanates:
their broad reactivity, their reversible interaction with cholinesterases, and the relative hydrolysis rates
of alkyl and aryl isocyanates. The broad reactivity of isocyanates as well as the demonstrated affinity
labeling of serine and sulfhydryl esterases are discussed. Extension of the affinity labeling studies to
include the analysis ofthe inhibition ofcholinesterases by methyl isocyanate showsthatmethyl isocyanate
is not an effective inhibitor of any of the cholinesterases. The inhibition of cholinesterases by alkyl
isocyanates shows a pattern of decreased specificity with decreased alkyl chain length. The inhibition of
cholinesterases by isocyanates is shown to be reversible, with a maximum rate of reversal seen at phys-
iological pH. This reversal is characteristic of the reaction of an isocyanate with a sulfhydryl group.
Finally, the affinity labeling of proteins must compete successfully with the hydrolysis of isocyanates in
aqueous solution. The hydrolysis ofalkyl isocyanates is shown to be significantly slower than that ofthe
aryl isocyanates.
The application of alkyl and aryl isocyanates to the
pesticide and polyurethane industries is of major com-
mercialinterest worldwide. In addition, the isocyanates
have proven to be valuable tools to protein chemists
making correlations between protein structure and
function. It is the information from these latter studies
that may prove valuable to our understanding of how
isocyanates affect human and animal populations. As a
reagentused forthestudyofprotein structure andfunc-
tion, isocyanates have two major characteristics that
make them attractive. First, they are highly reactive
with a variety of functional groups found on biological
macromolecules, and second, they have a finite lifetime
that enables them to react with selected functional
groups but not to exist longenough to cause significant,
nonspecific modification of the macromolecule under
study. It is the purpose ofthis paper to explore both of
these advantages of the isocyanates as protein modifi-
cation reagents, to summarize information already in
the literature, and to present new datarelevant to each
point. Of particular interest to this symposium will be
the comparison of the biochemical results for the aryl
isocyanates and the alkyl isocyanates. In the former
case, the emphasis willbe ontoluene diisocyanate (TDI)
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for which there is extensive toxicological information
(1), andinthelattercase, theemphasiswillbe onmethyl
isocyanate (MIC), which is the focus ofthis symposium.
The first point of discussion will be the reactivity of
the isocyanates. Table 1 shows the typical reactions of
isocyanates with different functional groups that occur
on proteins and other biological macromolecules. Vir-
tually every functional group gives a defined product
with anisocyanate undersome defined setofconditions.
For the purpose ofthis paper the discussion will center
only on those products that readily form under phys-
iological conditions and thus are potential sites of re-
actionunderexposure conditions. This narrowsthe can-
didates to the hydroxyl group (reaction 2), the
sulfhydryl group (reaction 3), and the imidazole group
(reaction 5). Although the other reactions are possible,
they are lessprobablebecause significantlyreducedlev-
els of the appropriate reactive form of the functional
group exist under physiological conditions. For exam-
ple, the amine reaction with the isocyanate is optimal
with a nonprotonated amine, and under physiological
conditions less than 5% of the protein amines are non-
protonated. As will be discussed later, the reaction of
the isocyanates with the hydroxyl group of serine has
been demonstrated to be the result ofthe modification
of the serine esterases (7). The modification of the ty-
rosyl-hydroxyl has been demonstrated with model com-
pounds (8) but has not been observed in proteins. InBROWN ET AL.
Table 1. Reactions of isocyanates (R-N=C=O) with biologically
relevant functional groups.
Reactive functional group Product Reference
0
H2N-R' 11 (2)
R-NH-C-NH-R'
0
HO-R' 1I (3)
R-NH-C-0-R'
0
HS-R' II (4)
R-NH-C-S-R'
0 00
11 11 11 (5)
HO-C-R' R-NH-C-0-C-R'
0
R-NHr--R' + CO2
o c
C = C -R' R-NH-C-N N
N N
RcN +_ _
H20 R-NH2 + C02
addition, the reaction with hydroxyl, R'OH, shown in
Table 1 is analogous to the hydrolysis reaction of the
isocyanate that results in the formation of carbon diox-
ide and the corresponding amine (Table 1). It is impor-
tant to note that any site-specific reaction that one de-
scribes is occurring in successful competition with this
hydrolysis reaction. This is an important consideration
in the case of the imidazole nitrogen reaction since al-
though it is a good nucleophile at physiological pH, the
reaction ofsecondary amines is slow relative to the rate
ofisocyanate hydrolysis.
Ofparticular interest is the reaction with the sulfhy-
dryl group that can occur at physiological pH, whose
product is stable under acidic conditions, but which is
fullyreversibleunderslightly alkalinepHconditions (8).
It is worth noting that the reversal of this reaction
proceeds through formation of the isocyanate (4). The
implication of this observation will be discussed later.
Finally, the imidazole group is a potential site of mod-
ification at physiological pH, and, although model com-
pounds have been synthesized, this specific modification
has not been observed in proteins to date. All of the
aforementioned reactions take place with both the alkyl
and aryl isocyantes.
The diverse reactivity ofthe isocyanates make them
attractive as potential molecular "rulers" to measure
structuralfeatures ofproteins. Tothisend, studies were
performed to measure the intramolecular distance be-
tween amino acids on a protein by crosslinking amino
acid side chains with bifunctional isocyanates ofdefined
dimensions (9). This analysis was extended to mono-
functionalisocyanates inthe caseoftheserineproteases
(chymotrypsin, trypsin, and elastase), and it was found
that not only did the isocyanates discriminate between
different esterases but they also demonstrated a chain-
length dependence forinhibition ofa single esterase (7).
Subsequent biochemical analysis showed that the re-
action was irreversible even in the presence of strong
nucleophilic reagents, the modification was on the ac-
tive-site serine 195inthe case ofchymotrypsin (10), and
that the alkyl chain was buried in the hydrophobic sub-
strate-bindingpocket ofthe enzyme (11). Thusthealkyl
isocyanates had been shown to be excellent active-site
directed affinity probes for the serine esterases. It is
worth noting that although these were in vitro exper-
iments, they were carried out at pH 7.5 and represent
stoichiometric inhibition ofthe enzymes in aqueous me-
dium.
Subsequent to this work, in vitro titrations of other
enzymes were performed; noteworthy among these
were papain and alcohol dehydrogenase (8), which were
both inhibited by butyl isocyanate. The major differ-
ences between these studies and those previously cited
for the serine esterases are that the inhibition of both
of these enzymes results from modification of their ac-
tive site sulfhydryl group and that the inhibition by the
isocyanates was reversible under slightly alkaline pH
(pH : 7.0).
Finally, it has been shown that in in vitro titrations
ofthecholinesteraseswithavarietyofisocyanates, both
alkyl and aryl, there is both inhibitory discrimination
of a single isocyanate for different cholinesterases and
ofdifferent isocyanates for a single cholinesterase (12).
This effect is similar to the same effect seen with other
anticholinesterases such as the organophosphates and
carbamates and has been discussed elsewhere (13). The
purpose of this paper is to extend the characterization
of the cholinesterase-isocyanate interaction to include
methyl isocyanate and to demonstrate that MIC is not
an effective inhibitor of the cholinesterases. Further-
more, it will be shown that the inhibition ofthe cholin-
esterases by other isocyanates is fully reversible under
physiological conditions.
The second point to be made in this paper is that
these site-specific stoichiometric inhibitions ofesterases
by isocyanates and indeed any site-directed affinity la-
beling of a protein by any isocyanate must compete
successfullywiththe simultaneous hydrolysis ofthe iso-
cyanates by water. Though substantial information is
available on the respiratory effects of the aryl isocya-
nates (1) and much has been presented at this meeting
on the effects of methyl isocyanate, little information
has been presented on the lifetime of the different is-
ocyanates in aqueous media. The results presented in
this paper will show that the alkyl isocyanates are sig-
nificantly more stable than the ayl isocyanates against
hydrolysis. This extended lifetime ofMIC may account
for the significant differences seen in the inhalation ir-
ritation between TDI and MIC.
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Methods
Materials
Horse serum cholinesterase (12.9 units/mg) and eel
cholinesterase (355 units/mg) were purchased from
Sigma Chemical Company and used without further pu-
rification. Human serum cholinesterase was purified
from plasma obtained from the Central Blood Bank of
Pittsburgh, PA. Purification to a specific activity of 150
units/mg was achieved by a combined purification
scheme of Main et al. (14) and Lockridge et al. (15).
Hexyl, butyl, o-tolyl, andp-tolyl monoisocyanates were
purchased from Eastman Organic Chemicals and have
a purity of98% or greater. Methyl isocyanate and hex-
amethylene diisocyanate were purchased from Aldrich
Chemical Company.
Enzyme Assays
Horse and human serum cholinesterases were as-
sayed according to the procedure of Ellman et al. (16)
with butyrylthiocholine (Sigma) as substrate. Eel cho-
linesterase was assayed by the same procedure, ace-
tylthiocholine (Sigma) beingused as substrate. One unit
of activity was defined as the hydrolysis of 1 ,umole of
butyrylthiocholine (or acetylthiocholine) per minute at
250C.
Cholinesterase Titration with Isocyanates
The titration of the cholinesterases was carried out
exactly as described previously (12). Initial protein con-
centrations were 1 mg/mL in 20 mM phosphate buffer,
pH 6.9, and the isocyanates were added as aliquots from
stock solutions ofisocyanates prepared in acetone. The
isocyanates were dissolved in acetone to facilitate their
solubility and dissolution in the aqueous reaction mix-
ture. The acetone never exceeded 10% of the final re-
action volume and was found to have no effect on cho-
linesterase activity in parallel experiments. The results
are expressed as percent of the initial activity of cho-
linesterase.
Reversal of Isocyanate Inactivation
Human serum cholinesterase (1 mg/mL) was titrated
with hexamethylene diisocyanate (HDI) as described in
the preceding section to 28% of its initial activity. The
final reaction mixture was adjusted to a pH of 7.5 and
incubated at room temperature. Aliquots of the ad-
justed reaction mixture were removed over a26-hrtime
period and immediately assayed for cholinesterase ac-
tivity. The results are expressed as the percent of the
sample's pretitration activity as afunction oftime. Sam-
ples titrated to lower initial remaining activity showed
recovery to a lower final level (data not shown).
pH Dependence of Reversibility
Human serum cholinesterase was titrated to 28% of
its initial activity with HDI at pH 6.9 as previously
described. Aliquots of the final reaction mixture were
incubated at different pH valuesfollowingtitrationwith
either acid (HCI) or base (NaOH) to the desired pH.
Aliquots from each of these incubations were removed
at prescribed time intervals, diluted into the assay
buffer, and immediately assayed in the standard assay
protocol. This procedure generated curves similar to
that in Figure 2 for each pH under study. From each
curve, the initial velocity for the recovery ofactivity at
a defined pH is measured. The final results are then
expressed as the rate of reactivation as a function of
pH.
Measurement of Hydrolysis Rates
The rates of hydrolysis of hexamethylene monoiso-
cyanate (HMI) and of o- and p-toluene monoisocyanate
(TMI) are being determined using proton nuclear mag-
netic resonance (NMR). All results reported here were
performed on the Bruker WH300 NMR instrument in
Dr. Chien Ho's laboratory at Carnegie-Mellon Univer-
sity. Utilization ofNMR for the kinetic studies made it
possible to accurately measure the quantity of water
present in the hydrolysis experiment, the quantity of
isocyanate present, the rate of disappearance of the
isocyanate, and the type of and rate of appearance of
all products and intermediates. This paper reports only
the rate ofisocyanate disappearance while a future pub-
lication will provide a complete analysis of the hydrol-
ysisofthesemonoisocyanates and certaindiisocyanates.
All hydrolysis experiments were performed under sim-
ilar conditions, and thus atypical protocol willbe given.
Experiments were performed in both deuterated di-
methyl sulfoxide (DMSO) and deuterated acetone.
These solvents were chosen because the solubility of
both water and the isocyanates in them provide a uni-
form miscible system. Acetone was the preferred sol-
vent in later experiments due to the observed catalytic
effect DMSO had on the hydrolysis reaction. A NMR
tube was filled with 1.0 mL ofsolvent, and the spectrum
wasmeasuredtodeterminetheamountofwaterpresent
in the sample. A measured quantity of water was then
added to the solvent such that the concentration was
between 0.11 and 3.33 M forthese experiments. A spec-
trum was taken to verify the water concentration. At
zero time, a measured quantity ofisocyanate was added
to the water-solvent mixture, and spectra were taken
at defined intervals. The first data point was collected
within 1.5 min of introduction and mixing of the iso-
cyanate, and data collection was computer-controlled,
with the most rapid sequence of time points being 30-
sec intervals. For each isocyanate, defined resonances
were identified that represented the unhydrolyzed is-
ocyanate-forexample, the protons onthe alphacarbon
for HMI. The second-order rate constants were derived
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from the slopes ofthe linear second-order plots for the
disappearance of the isocyanate in each case. The re-
ported rate constants represent the average ofat least
three experiments performed at concentrations of iso-
cyanaterangingfrom0.019to 1.08Mandconcentrations
ofwaterrangingfrom0.11to3.33 Mwithratiosofwater
to isocyanate ranging from 0.4 to 10.
Results and Discussion
In Vitro Effect of MIC on Cholinesterases
In experiments performed under conditions similar
to those previously used (12), eel acetyl cholinesterase
and equine serum butyryl cholinesterase were titrated
with methyl isocyanate. The results ofthese titrations
are illustrated in Figure 1. It can be seen that although
there is some discrimination between the two cholin-
esterases for methyl isocyanate, neither ofthe enzymes
are effectively inhibited by MIC. For comparison the
titration of serum cholinesterase by HDI is shown on
the graph to illustrate the effect of a stoichiometric in-
hibitor. Compiled inTable 2is acomparison ofthe effect
of different alkyl and aryl mono- and diisocyanates on
thetwocholinesterases. Thediisocyanatesgenerallyap-
pear to be the more potent inhibitors of the cholines-
terases, as discussed previously (12), while the alkyl
monoisocyanates show a marked dependence on chain
length, with the shorter chain isocyanates being the
poorer inhibitors. This is similar to the effect observed
with the inhibition of chymotrypsin by the alkyl iso-
cyanates and may reflect a decrease in the specific af-
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FIGURE 1. Titration of cholinesterases with methyl isocyanate:
horse serum cholinesterase in 20 mM phosphate buffer titrated
with () methyl isocyanate and (O) hexamethylene dilsocyanate;
(A) eel acetyl cholinesterase, under the same conditions titrated
with methyl isocyanate.
Table 2. Inhibition of cholinesterases by isocyanates at various
molar ratios of isocyanate/protein for 50% enzyme inhibition.
Isocyanate/protein ratio for
50% inhibitiona
Horse serum
Isocyanate enzyme Eel enzyme
Methyl isocyanate 51 560
Butyl isocyanate 10 109
Hexyl isocyanate 4.0 55
Hexamethylene diisocyanateb 3.2 1.8
2,6-Toluene diisocyanateb 0.8 202
2,4-Toluene diisocyanateb 68 700
aCalculations of molar ratios assumed that all protein was cholin-
esterase.
bData taken from a previous study (12) for comparison. Experi-
ments were performed under identical conditions.
finity making the protein reaction less competitive with
the hydrolysis reaction.
Reversible Nature of Isocyanate Inhibition
of Cholinesterases
Even though MIC is not an effective inhibitor ofcho-
linesterase, it is relevant to examine the characteristics
of the isocyanate-cholinesterase conjugates formed by
other isocyanates. In light of the reversible nature of
the BIC-papain and BIC-alcohol dehydrogenase modi-
fications (8), studies were conducted onthe reversibility
ofthe isocyanate-cholinesterase conjugates. In findings
reported earlier (17,18), it was found that upon incu-
bation of isocyanate-cholinesterase conjugates at pH
7.5, there is almost complete recovery ofthe enzymatic
activity. Reported herein are the previously unpub-
lished details of the experiments performed by our
group. Figure 2 shows the rate of the recovery of en-
zymatic activity at pH 7.5 for a sample ofhuman serum
cholinesterase whichhadbeeninitiallyinhibited byHDI
to 28% of control activity. Two characteristics of the
recovery can be seen in this plot. The first is the time
forreversal, this process appears to be complete within
7 hr. The second characteristic is that the reversal is
essentially complete (89% ofinitial activity). This latter
observation should be qualified by the fact that the cho-
linesterase was not completelyinhibited (i.e., the initial
reaction product ofthe isocyanate with the cholinester-
ase retained 28% ofits pre-inhibition activity). This in-
itial value for the reversibility experiments was chosen
because, as seen previously (12), the inhibition titration
curve is linear to this point, indicating a minimum of
nonspecific modification of the enzyme. Beyond this
point, nonspecific inhibition begins to appear that may
resultinlossofactivitybysecondsitemodification. Loss
of complete reversibility below this point may reflect
either involvement ofa second irreversible modification
that may also result in enzyme inhibition orirreversible
denaturation ofthe enzyme as a result ofthe more ex-
tensive modification.
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FIGURE 3. pH dependence ofthe recoveryofcholinesterase activity
following inhibition by isocyanate. Human serum cholinesterase,
inhibited to 28% of its original activity by HDI, is incubated at
room temperature under a variety of pH conditions. The initial
rate of reactivation at each pH was measured from plots similar
to those in Fig. 2.
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FIGURE 2. Rate of recovery of cholinesterase activity following in-
hibition by HDI. Human serum cholinesterase, inhibited to 28%
ofits original activity, is incubated at room temperature in 20mM
phosphate at pH 7.5.
pH Dependence of the Reversibility
The reversibility shows a marked pH dependence as
illustrated inFigure 3. The lowpH stability and alkaline
pH reversal are similar to those seen with the modifi-
cation ofthe active site sulfhydryl in papain and alcohol
dehydrogenase (3). Unlike papain and alcohol dehydro-
genase, however, this loss ofreactivation at high pH is
not due to irreversible denaturation of the enzyme at
these pH values since control experiments show reten-
tion ofactivity ofunmodified enzyme up to pH 10. This
loss ofreactivation may be due either to induced insta-
bility in the enzyme as aresult ofthe initial modification
by the isocyanate or to shift of the isocyanate from a
reversibly modified active site amino acid (i.e., a sulfhy-
drylgroup) to anirreversibly modified active-site amino
acid (e.g., ahydroxyl or an amino group). As mentioned
above, the modification of a sulfhydryl by an isocyanate
yields aproductthatisreversibleunderslightly alkaline
pH and proceeds through the isocyanate functional
group before either being hydrolyzed or reacting with
another strong nucleophile, such as the amino group
aboveitspKa. Thissuggeststhat asulfhydrylcontaining
protein or peptide may act as a carrier ofthe isocyanate
group for possible reaction upon its release at a later
time and/or place. Although no direct evidence exists
for this mechanism under physiological conditions, it is
certainly a hypothesis that can be tested with the use
of labeled isocyanates.
Relative Hydrolysis of Alkyl and Aryl
Isocyanates
Because of the vast amount of information available
ontherespiratory effects ofTDI (1) andthe mostrecent
observations of the respiratory effects of MIC (19), it
was thought that the finding ofpulmonary sensitization
observed with MIC and not with TDI under similar
conditions might be explained by the difference in their
lifetimein aqueousenvironments. Frompreviouslypub-
lished data (7) it was found that the rate of disappear-
ance of the alkyl isocyanates, BIC and HMI, was sec-
ond-order as expected and was the same for the two
alkylisocyanates withinexperimental error. This would
suggest that there may be no significant difference in
the rate of hydrolysis of the alkyl monoisocyanates as
a function of the alkyl chain length. Thus MIC would
have a half-life of approximately 2 min in an aqueous
phosphate-buffered solution at pH 7.5 (the conditions
chosen for the in vitro inhibition studies of the serine
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esterases). As mentioned previously, the finite lifetime
of a reagent is a characteristic that is beneficial in in
vitro protein chemical modification studies since the re-
agent would be stable enough for site-specific modifi-
cations but would hydrolyze before extensive nonspe-
cific modifications would take place. However, under in
vivo physiological conditions, where a variety ofdiffer-
ent proteins exist simultaneously at very high concen-
trations, the potential for nonspecific modification is
greatly increased. Therefore, the longer a reagent's re-
active lifetime, the more potential a reagent has for
extensive modification ofbiological macromolecules. To
understand the differences in the pulmonary effects of
MIC and TDI, it thus became important to determine
the relative difference in hydrolysis rates between the
alkylandarylisocyanates. Table3liststhesecond-order
rate constants determined for the hydrolysis of HMI
and o- and p-toluene monoisocyanates (o-TMI, p-TMI).
Although performed at stoichiometric rather than sat-
urating conditions of water concentration, the relative
hydrolysis rates ofthe alkyl and aryl isocyanates would
indicate a 5- to 1400-fold faster rate for the hydrolysis
of the aryl monoisocyanates over the alkyl monoiso-
cyanate, depending onthe isomerofarylisocyanate and
the solvent chosenforthestudy. Itisknownthat DMSO
enhances certain organic reactions and thus the data
collected in acetone may be the most significant; how-
ever, emphasis should be placed on the relative com-
parison ofthe rates in each solvent ratherthanbetween
solvents. These results would support the speculation
that the greater pulmonary sensitization seen with the
MIC relative to TDI (19) may in part be due to the
longer lifetime ofMIC inthe airways due to arelatively
slower rate of hydroysis. These rates are meant to il-
lustrate relative rates and at this point in our investi-
gation do not represent absolute values for the aqueous
hydrolysis rates.
In summary, the data thus far would indicate that
MIC has a relatively long lifetime, is highly reactive,
and is not an anticholinesterase reagent. In addition,
the lack ofefficient inhibition ofcholinesterase by MIC
and the reversibility ofthe inhibition by other isocyan-
ates in the in vitro experiments might explain the in-
ability of in vivo exposure experiments to show any
effect on serum cholinesterase (20). Thus the destruc-
tivenature ofMIC maybeduetoindiscriminantlabeling
of biological macromolecules. At this point it is worth
mentioning the recent presentation of data from the
exposure of guinea pigs to radioactively labeled TDI
Table 3. Second-order rate constants for the hydrolysis
of isocyanates under controlled aqueous conditions.
Second-order rate
constant/M-min
Isocyanate In DMSO In acetone
Hexamethylene monoisocyanate 5.4 x 1O-3 4.1 X 10-4
o-Tolyl monoisocyanate 1.8 x 10-1 1.9 x 10-3
p-Tolyl monoisocyanate 7.68 ND
(21). The results of these studies indicate that TDI is
taken up in the blood ofthe animals in a dose-response
manner with no significant difference between animals
previously sensitized to TDI and nonsensitized animals.
In addition, all of the radioactivity in the blood of the
exposed animals appears irreversibly attached to a sin-
gle protein species of 71,000 molecular weight. These
results would indicate avery specific mechanism forthe
interaction of TDI with the physiological system. Al-
though the data reported here would indicate real dif-
ferences between the alkyl and aryl isocyanates in their
reaction specificity and hydrolysis rates, it is intriguing
to speculate as to whether there is a similarity in the
uptake ofthe MIC and TDI physiologically. Again, this
is a question that can be resolved with the aid of a
labeled MIC probe.
This investigation was supported in part by a grant from the Win-
ters Foundation to Dr. Brown.
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